GEN vs LEXXW · P/E 17, rev $5.00B vs rev $705.9K
Gen Digital Inc. (GEN) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the GEN and LEXXW stock pages for the full models.
Not investment advice.